Sartorius Stedim Biotech Investor Relations Material
Latest events
Q1 2025
Sartorius Stedim Biotech
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Sartorius Stedim Biotech S.A.
Access all reports
Sartorius Stedim Biotech S.A. is a global supplier of biopharmaceutical equipment and services, specializing in the development of products used in the manufacture of vaccines, biologics, and cell-based therapies. The company offers a wide range of solutions, including bioreactors, filtration systems, and single-use technologies, aimed at optimizing and accelerating biopharmaceutical production processes. The company is headquartered in Aubagne, France, and its shares are listed on Euronext Paris.
Key slides for Sartorius Stedim Biotech S.A.
Q1 2025
Sartorius Stedim Biotech S.A.
Q1 2025
Sartorius Stedim Biotech S.A.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
DIM
Country
🇫🇷 France